Artificial Intelligence-based Segmentation of Residual Pancreatic Cancer in Resection Specimens Following Neoadjuvant Treatment (ISGPP-2)
Boris V. Janssen(Amsterdam University Medical Centers), Casper Jansen(Thales (Netherlands)), Marc G. Besselink(Amsterdam Neuroscience), Aslihan Yavas(Düsseldorf University Hospital), Caroline S. Verbeke(Oslo University Hospital), Volkan Adsay(Koç University), Mahsoem Ali(Amsterdam Neuroscience), Anthony J. Gill(The University of Sydney), Anubhav Mittal(The University of Sydney), Joanne Verheij, Jas Samra(The University of Sydney), Arantza Fariña Sarasqueta(Leiden University), Mike Kliffen(Maasstad Ziekenhuis), Geert Kazemier(European Organisation for Research and Treatment of Cancer), Iréne Esposito(Heinrich Heine University Düsseldorf), Seung‐Mo Hong(Ulsan College), Deyali Chatterjee(The University of Texas MD Anderson Cancer Center), Marie‐Louise F. van Velthuysen(Erasmus MC), Paul Drillenburg(Amsterdam UMC Location University of Amsterdam), Stijn Crobach, Olca Baştürk(Memorial Sloan Kettering Cancer Center), P. Valkema(Amsterdam University Medical Centers), Onno J. de Boer(Amsterdam University Medical Centers), Ewout W. Steyerberg(Erasmus MC), Bart Oteman(Amsterdam University Medical Centers), Huamin Wang(The University of Texas MD Anderson Cancer Center), Angela Chou(Royal North Shore Hospital), Michael Doukas(Erasmus MC)
Cited by 5
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Assessing the Performance of Prediction Models
|Epidemiology|2009|4.9k